2026

• HY Kim, HB Kim, JH Park, MJ Kim, JH Byun, SH Oh. (2026) Simultaneous regeneration of epithelial and bone tissue using a multifunctional film with leaf-stacked structures and growth factors. Biomater Sci. 

2025

• HM Jeon*, HS Noh*, MG Jeon, JH Park, YS Lee, G Seo, YH Cheon, M Kim, MK Han, JY Park, Lee SI. (2025) The HRAS-binding C2 domain of PLCη2 suppresses tumor-like synoviocytes and experimental arthritis in rheumatoid arthritis. Exp Mol Med. 

• JH Park, HS Bae, I Kim, J Jung, Y Roh, D Lee, TS Hwang, HC Lee, JH Byun. (2025) Efficacy of bone regeneration cell therapy using mesenchymal stem cells originating from embryonic stem cells in animal models; bone defects and osteomyelitis. Tissue Eng Regen Med. 

2024

• EK Choi, TM Rajendiran, T Soni, JH Park, L Aring, CK Muraleedharan, V Garcia-Hernandez, N Kamada, LC Samuelson, A Nusrat, S Iwase, YA Seo. (2024) The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease. Nat Commun.

• MJ Kim*, JH Park*, JM Seok*, J Jung, TS Hwang, HC Lee, JH Lee, SA Park, JH Byun, SH Oh. (2024) BMP-2-immobilized PCL 3D printing scaffold with a leaf-stacked structure as a physically and biologically activated bone graft. Biofabrication.

• YJ Seo*, JH Park*, JH Byun. (2024) Therapeutic potential of Stearoyl-CoA Desaturase1 (SCD1) in modulating the effects of fatty acids on osteoporosis. Cells.

2023

• JH Park, YJ Seo, HS Oh, JH Byun. (2023) Effects of myeloid immune cells on the metabolic process of biomimetic bone regeneration. Life Sci.

• JM Seok*, MJ Kim*, JH Park, D Kim, D Lee, SJ Yeo, JH Lee, K Lee, JH Byun, SH Oh, SA Park. (2023) A bioactive microparticle-loaded osteogenically enhanced bioprinted scaffold that permits sustained release of BMP-2. Mater Today Bio.

2022

• MJ Kim*, JH Park*, JH Lee, HJ Kim, HJ Choi, HC Lee, JH Lee, JH Byun, SH Oh. (2022) Bioactive porous particles as biological and physical stimuli for bone regeneration. ACS Biomater Sci Eng.

• DS Kim*, JH Park*, TY Kim, DG Kim, JH Byun, HS Kim. (2022) Enhanced half-life and antitumor activity of interleukin-15 through genetic fusion of a serum albumin-specific protein binder. Int J Pharm. *Young Investigator Award (President Prize)

2021

• JH Park, SA Park, YH Kang, SM Hwa, EB Koh, SC Hwang, SH Oh, JH Byun. (2021) Zinc sulfate stimulates osteogenic phenotypes in periosteum-derived cells and co-cultures of periosteum-derived cells and THP-1 cells. Life. 

• HY Kim*, JH Park*, MJ Kim, JH Lee, SH Oh, JH Byun. (2021) The effects of VEGF-centered biomimetic delivery of growth factors on bone regeneration. Biomater Sci. *Young Investigator Award

• M Kim*, Y Choe*, H Lee*, MG Jeon, JH Park, HS Noh, YH Cheon, HJ Park, J Park, SJ Shin, K Lee, SI Lee. (2021) Blockade of translationally controlled tumor protein attenuated the aggressiveness of fibroblast-like synoviocytes and ameliorated collagen-induced arthritis. Exp Mol Med. 

2020

• JH Park, YH Kang, SC Hwang, SH Oh, JH Byun. (2020) Parthenolide has negative effects on In vitro enhanced osteogenic phenotypes by inflammatory cytokine TNF-α via inhibiting JNK signaling. Int J Mol Sci. 

• TY Kim, YR Nam, JH Park, DE Lee, HS Kim. (2020) Site-specific lipidation of a small-sized protein binder enhances the antitumor activity through extended blood half-life. ACS Omega.

• S Jeong, YK Sohn, Y Choi, JH Park, HS Kim. (2020) A regulatory SH2 domain-targeting protein binder effectively inhibits the activity of Bruton’s tyrosine kinase and its drug-resistant variants. Biochem Biophys Res Commun.

2019

• TY Kim*, JH Park*, HE Shim, DS Choi, DE Lee, JJ Song, HS Kim. (2019) Prolonged half-life of small-sized therapeutic protein using serum albumin-specific protein binder. J Control Release.

• S Son, JH Park, H Seo, HT Lee, YS Heo, HS Kim. (2019) A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model. J Drug Target.

2017

• JH Park, BW Park, YH Kang, SH Byun, SC Hwang, DR Kim, DK Woo, JH Byun. (2017) Lin28a enhances in vitro osteoblastic differentiation of human periosteum-derived cells. Cell Biochem Funct.

• JH Lee, DK Woo, TH Kim, JG Kang, JW Yun, JH Park, BW Park, YH Kang, GJ Rho, SJ Jang, JS Park, HC Lee, YM Yoon, TS Hwang, DR Kim, SC Hwang, DH Lee, HY Kim, SH Oh, JH Byun. (2017) In vitro and long-term (2-year follow-up) in vivo osteogenic activities of human periosteum-derived osteoblasts seeded into growth factor-releasing polycaprolactone/pluronic F127 beads scaffolds. J Biomed Mater Res A. 

2016

• JE Chung, JH Park, JW Yun, YH Kang, BW Park, SC Hwang, YC Cho, IY Sung, DK Woo, JH Byun. (2016) Cultured human periosteum-derived cells can differentiate into osteoblasts in a perioxisome proliferator-activated receptor gamma-mediated fashion via bone morphogenetic protein signaling. Int J Med Sci.

• HY Kim, JH Lee, JW Yun, JH Park, BW Park, GJ Rho, SJ Jang, JS Park, HC Lee, YM Yoon, TS Hwang, DH Lee, JH Byun, SH Oh. (2016) Development of porous beads to provide regulated BMP-2 stimulation for varying durations: In vitro and in vivo studies for bone regeneration. Biomacromolecules.